K. Wojas-Krawczyk

发表

Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients—Mechanism of Action and Future Concepts

P. Krawczyk, M. Strzemski, K. Wojas-Krawczyk, 2021, Cancers.

Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research

T. Kubiatowski, K. Wojas-Krawczyk, 2020, Frontiers in Oncology.

Aptamers in Non-Small Cell Lung Cancer Treatment

P. Krawczyk, K. Wojas-Krawczyk, I. Wieleba, 2020, Molecules.

Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, International journal of molecular sciences.

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.

P. Krawczyk, J. Milanowski, J. Szumiło, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

P. Krawczyk, W. Olszewski, M. Krzakowski, 2012, Respiration.

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021, Scientific Reports.

Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer

P. Krawczyk, J. Milanowski, J. Pankowski, 2015, Tumori.

EGFR gene mutations in patients with adenosquamous lung carcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2014, Asia-Pacific journal of clinical oncology.

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report.

P. Krawczyk, J. Milanowski, E. Czekajska-Chehab, 2014, Anticancer research.

The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients

P. Krawczyk, J. Milanowski, T. Trojanowski, 2014, Pathology & Oncology Research.

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Oncology letters.

Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique

P. Krawczyk, J. Milanowski, R. Ramlau, 2020 .

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression — focus on intestinal microbiome

P. Krawczyk, J. Milanowski, I. Chmielewska, 2020 .

New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary

P. Krawczyk, W. Olszewski, R. Dziadziuszko, 2022, Cancers.

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.

P. Krawczyk, J. Milanowski, A. Emeryk, 2017, Pulmonary pharmacology & therapeutics.

The Effect of CD14 and TLR4 Gene Polymorphisms on the Occurrence of Atopic and Non-Atopic Asthma

J. Milanowski, M. Grzybek, T. Zaborowski, 2011 .

[Evaluation of Th1/Th2 lymphocyte balance and lipopolysaccharide receptor expression in asthma patients].

P. Krawczyk, J. Milanowski, T. Zaborowski, 2009, Pneumonologia i alergologia polska.

The impact of intestinal microflora on the effectiveness of immunotherapy with antibodies against immune checkpoints — case report and literature review

M. Szczyrek, P. Krawczyk, J. Milanowski, 2018, Oncology in Clinical Practice.

Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, Biology.

Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?

M. Szczyrek, A. Zwolak, I. Chmielewska, 2021, PloS one.

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, J. Szumiło, 2019, Cancer genetics.

Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma

M. Szczyrek, P. Krawczyk, J. Milanowski, 2017 .

Dendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patway.

P. Krawczyk, J. Milanowski, I. Homa-Mlak, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Scientific reports.

Differential diagnosis of autoimmune pituitary failure and pituitary macroadenoma during nivolumab therapy in an NSCLC patient — a case report

P. Krawczyk, J. Milanowski, R. Kieszko, 2019, Oncology in Clinical Practice.

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

P. Krawczyk, J. Milanowski, G. Wallner, 2020, BMC Gastroenterology.

Direct spectroscopic and GC profiling combined with chemometric analysis as an alternative approach to investigate Hypericum species: Is it possible to replace HPLC?

S. Dresler, J. Kováčik, I. Sowa, 2020 .

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, Cells.

Reply to the letter to the editor ‘ Prevalence of rare EGFR mutations in non-small cell lung cancer: a multicenter study on 3856 Polish Caucasian patients ’

P. Krawczyk, J. Milanowski, R. Ramlau, 2016 .

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study.

P. Krawczyk, J. Milanowski, R. Mlak, 2012, Folia histochemica et cytobiologica.

Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion—Which Path Should We Follow? Case Reports and Literature Review

M. Krzakowski, D. Kowalski, K. Wojas-Krawczyk, 2022, Journal of clinical medicine.

A Chemometry of Aldrovanda vesiculosa L. (Waterwheel, Droseraceae) Populations

Anna Danielewicz, L. Adamec, S. Dresler, 2020, Molecules.

Toxicity of Carlina Oxide—A Natural Polyacetylene from the Carlina acaulis Roots—In Vitro and in Vivo Study

P. Krawczyk, A. Michalak, S. Woźniak, 2020, Toxins.

Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, International journal of molecular sciences.

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Frontiers in Oncology.

Screening of Gene Mutations in Lung Cancer for Qualification to Molecularly Targeted Therapies

P. Krawczyk, Paweł Krawczyk, Tomasz Kucharczyk, 2012 .

Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer

P. Krawczyk, K. Wojas-Krawczyk, M. Nicoś, 2021, International journal of molecular sciences.

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

P. Krawczyk, J. Milanowski, E. Kalinka, 2019, International journal of molecular sciences.

Preventing central nervous system metastases in non-small cell lung cancer

P. Krawczyk, D. Kowalski, R. Duchnowska, 2018, Expert review of anticancer therapy.

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

P. Krawczyk, J. Milanowski, J. Szumiło, 2017, Oncotarget.

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer

M. Szczyrek, J. Milanowski, R. Mlak, 2022, Cells.

Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2021, International journal of molecular sciences.

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer

P. Krawczyk, J. Milanowski, D. Kowalski, 2012, Contemporary oncology.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

P. Krawczyk, J. Milanowski, R. Dziadziuszko, 2014, Journal of Cancer Research and Clinical Oncology.

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Oncology reports.

Predictive value of ERCC 1 and RRM 1 gene single-nucleotide polymorphisms for first-line platinum-and gemcitabine-based chemotherapy in non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2013 .

The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors

P. Krawczyk, J. Milanowski, M. Krzakowski, 2012, Chemotherapy.

The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients

P. Krawczyk, J. Milanowski, M. Krzakowski, 2011, Respiration.

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report.

P. Krawczyk, J. Milanowski, J. Roliński, 2009, Folia histochemica et cytobiologica.

Viral Infection and Lung Cancer Immunotherapy

I. Chmielewska, E. Kalinka, K. Wojas-Krawczyk, 2021, Frontiers in Oncology.

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review

M. Szczyrek, A. Zwolak, I. Chmielewska, 2020, Cancers.

Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report

P. Krawczyk, J. Milanowski, E. Czekajska-Chehab, 2012, Archivum Immunologiae et Therapiae Experimentalis.

Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2018, Brain pathology.

The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients

P. Krawczyk, J. Milanowski, M. Grzybek, 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2014, Journal of Cancer Research and Clinical Oncology.

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Archives of medical science : AMS.

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Pathology & Oncology Research.

In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka

P. Krawczyk, M. Latalski, M. Wójciak-Kosior, 2017, Front. Pharmacol..

The Influence of Different Anti-PD-1 Monoclonal Antibody Concentrations On T Cell Activation in in - Vitro Culture – A Preliminary Study

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021 .

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

P. Krawczyk, R. Dziadziuszko, M. Krzakowski, 2014, Pneumonologia i alergologia polska.

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer

M. Szczyrek, P. Krawczyk, J. Milanowski, 2016, Pathology & Oncology Research.

Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2018, Journal of thoracic disease.

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Balkan Journal of Medical Genetics : BJMG.

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique

P. Krawczyk, J. Milanowski, T. Trojanowski, 2017, Clinical and Translational Oncology.

Double Guard Efficiency and Safety—Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients

P. Krawczyk, E. Kalinka, K. Wojas-Krawczyk, 2023, Cancers.

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Contemporary oncology.

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.

P. Krawczyk, J. Milanowski, A. Emeryk, 2017, Pulmonary Pharmacology & Therapeutics.

The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients

P. Krawczyk, J. Milanowski, M. Krzakowski, 2011, Respiration.

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report.

P. Krawczyk, J. Milanowski, J. Roliński, 2009, Folia histochemica et cytobiologica.

Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Oncology in Clinical Practice.

Predictive factors testing proposal for NSCLC patients during the COVID-19 pandemic

P. Krawczyk, R. Dziadziuszko, D. Kowalski, 2021, Expert review of anticancer therapy.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, R. Ramlau, A. Szczesna, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival analysis of advanced lung cancer patients undergoing personalised treatment or chemotherapy in a real clinic

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021 .

Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2

P. Krawczyk, A. Grenda, K. Wojas-Krawczyk, 2024, BMC infectious diseases.